SEC Form 4 Filing for Novavax Inc.

Charles W. Newton, a director at Novavax Inc., reported a transaction on April 25, 2026. He acquired 9,520 shares of Common Stock with a transaction price of $0.00. Following this transaction, Mr. Newton directly owns 9,520 shares of Common Stock. Additionally, Mr. Newton was granted 9,520 Restricted Stock Units (RSUs), which are convertible into Common Stock. These RSUs vest over three years, with one-third vesting annually on April 25th, provided Mr. Newton continues to serve on the Board of Directors. Each RSU represents a contingent right to receive one share of Novavax Inc. common stock upon vesting. The total number of shares Mr. Newton owns after these transactions, including the RSUs, amounts to 19,040.